Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Appropriations

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Appropriations ₹6,351 Cr₹4,681 Cr₹3,382 Cr₹2,738 Cr₹2,680 Cr

What is the latest Appropriations of NATCO PHARMA ?

The latest Appropriations ratio of NATCO PHARMA is ₹6,351 Cr based on Mar2026 Consolidated results.
Year Appropriations
Mar2026₹6,351 Cr
Mar2025₹4,681 Cr
Mar2024₹3,382 Cr
Mar2023₹2,738 Cr
Mar2022₹2,680 Cr

How is Appropriations of NATCO PHARMA Trending?

Years Appropriations % Change
Mar2026 ₹6,351 Cr
35.69
Mar2025 ₹4,681 Cr
38.40
Mar2024 ₹3,382 Cr
23.51
Mar2023 ₹2,738 Cr
2.17
Mar2022 ₹2,680 Cr -

Compare Appropriations of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,798.1 Cr -1.4% -8.9% -3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.4%

-8.9%

-3.5%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses